arcopenia, lung disease and mortality: a secondary analysis of the CRELES study

Geriatrics, Gerontology and Aging

Endereço:
Avenida Nossa Senhora de Copacabana,500 - 609 - Copacabana
Rio de Janeiro / RJ
22020001
Site: http://ggaging.com
Telefone: (21) 2285-8115
ISSN: 2447-2123
Editor Chefe: Roberto Alves Lourenço
Início Publicação: 10/10/2007
Periodicidade: Trimestral
Área de Estudo: Educação física, Área de Estudo: Enfermagem, Área de Estudo: Farmácia, Área de Estudo: Fisioterapia e terapia ocupacional, Área de Estudo: Fonoaudiologia, Área de Estudo: Medicina, Área de Estudo: Nutrição, Área de Estudo: Odontologia, Área de Estudo: Saúde coletiva, Área de Estudo: Serviço social, Área de Estudo: Multidisciplinar

arcopenia, lung disease and mortality: a secondary analysis of the CRELES study

Ano: 2019 | Volume: 13 | Número: 1
Autores: Miguel Germán Borda; Daniela Patino-Hernandez; Carlos Alberto Cano-Gutiérrez; Carlos Andrés Celis-Preciado; Mario Ulises Pérez-Zepeda
Autor Correspondente: Daniela Patino-Hernandez | [email protected]

Palavras-chave: sarcopenia; chronic obstructive pulmonary disease; mortality; aged.

Resumos Cadastrados

Resumo Inglês:

AIM: Chronic obstructive pulmonary disease (COPD) is a pro-inflammatory condition leading to wasting states such as sarcopenia. We aimed to describe the effect of COPD and sarcopenia on mortality in Costa Rican older adults in the Costa Rican Longevity and Healthy Aging Study (CRELES).
METHOD: This is a secondary analysis of the CRELES, a cohort study consisting of three waves of interviews. For the current study, data from the first and third waves were used. The dependent variable was survival status. COPD and sarcopenia were independent variables. Bivariate analyses were used to compare mortality curves for each group. Association with 3-year mortality was tested with Cox regression models, and hazard ratios (HR) with 95% confidence intervals (CI) were estimated as a measure of the strength of association.
RESULTS: Of a total of 2704 participants, 54.29% (n = 1468) were women. Overall mortality was 9.05%. Sarcopenic older adults had the strongest association with mortality (HR = 2.65; 95%CI, 1.81–3.90; p < 0.001), followed by those with both COPD and sarcopenia (HR = 2.59; 95%CI, 1.37–4.92; p = 0.003). The weakest association with mortality was found in patients with neither COPD nor sarcopenia. CONCLUSIONS: The synergistic effect of sarcopenia and COPD has been shown to independently increase mortality in older patients. Our results may be applicable to both Latin American residents and subjects of Hispanic descent living in developed countries. Sarcopenia should be assessed in all patients with COPD since the latter is not a disease limited to the lungs, but rather a systemic disease.